Variations in microbicide gel acceptability among young women in the USA and Puerto Rico

Culture, Health and Sexuality

Volumn 14, Issue 2, 2012, Pages 151-166

  Giguere, Rebecca ^a   Carballo Diéguez, Alex ^a   Ventuneac, Ana ^b   Mabragaña, Marina ^a   Dolezal, Curtis ^a   Chen, Beatrice A ^c,d   Kahn, Jessica A ^e   Zimet, Gregory D ^f   McGowan, Ian ^c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV risk; microbicide acceptability; Puerto Rico; USA; young women

Indexed keywords

AGENTS USED INTRAVAGINALLY; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURAL FACTOR; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MULTICENTER STUDY; PATIENT ATTITUDE; PHASE 1 CLINICAL TRIAL; PSYCHOLOGICAL ASPECT; PUERTO RICO; RANDOMIZED CONTROLLED TRIAL; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

ANTI-INFECTIVE AGENTS, LOCAL; CULTURAL CHARACTERISTICS; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; PATIENT ACCEPTANCE OF HEALTH CARE; PUERTO RICO; SEXUALLY TRANSMITTED DISEASES; UNITED STATES; VAGINAL CREAMS, FOAMS, AND JELLIES; YOUNG ADULT;

EID: 84859150481     PISSN: 13691058     EISSN: 14645351     Source Type: Journal    
DOI: 10.1080/13691058.2011.630099     Document Type: Article

References (35)

1. Abdool Karim, Q., Abdool Karim, S.S., Frohlich, J.A., Grobler, A.C., Baxter, C., Mansoor, L.E.Kharsany, A.B.M. 2010. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science, 329(5996): 1168-74.
2. Bentley, M.E., Fullem, A.M., Tolley, E.E., Kelly, C.W., Jogelkar, N., Srirak, N.Mwafulirwa, L. 2004. Acceptability of microbicide among women and their partners in a 4-country phase I trial. American Journal of Public Health, 94(7): 1159-64.
3. Braunstein, S. and Van de Wijgert, J. 2005. Preferences and practices related to vaginal lubrication: Implications for microbicide acceptability and clinical testing. Journal of Women's Health, 14(5): 424-33.
4. Carballo-Diéguez, A., R. Giguere, C. Dolezal, B.A. Chen, J. Kahn, G. Zimet, and M. Mabragaña. et al. 2011. 'Tell Juliana': Acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a Phase 1 microbicide study. AIDS and Behavior. 24 Aug 2011. [Epub ahead of print], doi: 10.1007/s10461-011-0028-6
5. CDC. 2008. Subpopulation estimates from the HIV incidence surveillance system-United States, 2006. Morbidity and Mortality Weekly Report, 57: 985-989. CDC. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5736a1.htm
6. CDC. 2009. Incidence and diagnoses of HIV infection-Puerto Rico, 2006. Morbidity and Mortality Weekly Report, 58: 589-591. CDC. http://cdc.gov/mmwr/preview/mmwrhtml/mm5821a3.htm
7. Coggins, C., Blanchard, K. and Friedland, B. 2000. Men's attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the United States. Reproductive Health Matter, 8(15): 132-41.
8. Cottrell, B.H. 2010. An updated review of evidence to discourage douching. American Journal of Maternal Child Nursing, 35(2): 102-7.
9. Edelman, A., Lew, R., Cwiak, C., Nichols, M. and Jensen, J. 2007. Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women. Contraception, 75(6): 450-3.
10. Global Campaign for Microbicides. 2009. About microbicides 2009. Global Campaign for Microbicides.http://www.global-campaign.org/about_microbicides.htm
11. Greene, E., Batona, G., Hallad, J., Johnson, S., Neema, S. and Tolley, E.E. 2010. Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India. Culture, Health & Sexuality, 12(7): 739-54.
12. Hammett, T.M., Mason, T.H., Joanis, C.L., Foster, S.E., Harmon, P., Robles, R.Finlinson, H. 2000. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: Results of product trials in three cities. Sexually Transmitted Diseases, 27(2): 119-26.
13. Hammett, T.M., Norton, G.D., Mason, T.H., Langenbahn, S., Mayer, K.H., Robles, R.R.Feudo, R. 2000. Drug-involved women as potential users of vaginal microbicides for HIV and STD prevention: A three-city survey. Journal of Women's Health & Gender-Based Medicine, 9(10): 1071-80.
14. Hoffman, S., Morrow, K.M., Mantell, J.E., Rosen, R.K., Carballo-Diéguez, A. and Gai, F. 2010. Covert use, vaginal lubrication and sexual pleasure: A qualitative study of urban US women in a vaginal microbicide clinical trial. Archives of Sexual Behavior, 39(3): 748-60.
15. Johnston-Robledo, I., Ball, M., Lauta, K. and Zekoll, A. 2003. To bleed or not to bleed: Young women's attitudes toward menstrual suppression. Women & Health, 38(3): 59-75.
16. MacQueen, K.M., McLellan, E., Kay, K. and Milstein, B. 1998. Codebook development for team-based qualitative analysis. Field Methods, 10(2): 31-6.
17. Mantell, J.E., Myer, L., Carballo-Diéguez, A., Stein, Z., Ramjee, G., Morar, N.S. and Harrison, P.F. 2005. Microbicide acceptability research: Current approaches and future directions. Social Science & Medicine, 60(2): 319-30.
18. Mason, T.H., Foster, S.E., Finlinson, H.A., Morrow, K.M., Rosen, R., Vining, S.Joanis, C.L. 2003. Perspectives related to the potential use of vaginal microbicides among drug-involved women: Focus groups in three cities in the United States and Puerto Rico. AIDS and Behavior, 7(4): 339-51.
19. McGowan, I., Gomez, K., Bruder, K., Febo, I., Chen, B.A., Richardson, B.A.Husnik, M. 2011. Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004). AIDS, 25(8): 1057-64.
20. McKee, M.D., Baquero, M., Anderson, M.R., Alvarez, A. and Karasz, A. 2009. Vaginal douching among Latinas: Practices and meaning. Maternal and Child Health Journal, 13(1): 98-106.
21. Montgomery, C.M., Gafos, M., Lees, S., Morar, N.S., Mweemba, O., Ssali, A.Stadler, J. 2010. Re-framing microbicide acceptability: Findings from the MDP301 trial. Culture, Health & Sexuality, 12(6): 649-62.
22. Morrow, K.M., Fava, J.L., Rosen, R.K., Christensen, A.L., Vargas, S. and Barroso, C. 2007. Willingness to use microbicides varies by race/ethnicity, experience with prevention products and partner type. Health Psychology, 26(6): 777-86.
23. Morrow, K.M. and Ruiz, M.S. 2008. Assessing microbicide acceptability: A comprehensive and integrated approach. AIDS and Behavior, 12(2): 272-83.
24. Patton, M.Q. 2002. Qualitative research & evaluation methods, 3rd ed., Thousand Oaks, CA: Sage.
25. Population Services International. 2009. HIV/AIDS statistics. Population Services International. http://projects.psi.org/site/PageServer?pagename=Statistics_nr
26. Rosen, R.K., Morrow, K.M., Carballo-Diéguez, A., Mantell, J.E., Hoffman, S., Gai, F.Maslankowski, L. 2008. Acceptability of tenofovir gel as a vaginal microbicide among women in a Phase I trial: A mixed-methods study. Journal of Women's Health, 17(3): 383-92.
27. Scorgie, F., Smit, J.A., Kunene, B., Martin-Hilber, A., Beksinska, M. and Chersich, M.F. 2011. Predictors of vaginal practices for sex and hygiene in KwaZulu-Natal, South Africa: Findings of a household survey and qualitative inquiry. Culture, Health & Sexuality, 13(4): 381-98.
28. Severy, L.J. and Newcomer, S. 2005. Critical issues in contraceptive and STI acceptability research. Journal of Social Issues, 61(1): 45-65.
29. Severy, L.J., Tolley, E., Woodsong, C. and Guest, G. 2005. A framework for examining the sustained acceptability of microbicides. AIDS and Behavior, 9(1): 121-31.
30. Stadler, J. and Saethre, E. 2011. Blockage and flow: Intimate experiences of condoms and microbicides in a South African clinical trial. Culture, Health & Sexuality, 13(1): 31-44.
31. Tanner, A.E., Fortenberry, J.D., Zimet, G.D., Reece, M., Graham, C.A. and Murray, M. 2010. Young women's use of a microbicide surrogate: The complex influence of relationship characteristics and perceived male partners' evaluations. Archives of Sexual Behavior, 39(3): 735-47.
32. Tanner, A.E., Zimet, G., Fortenberry, J.D., Reece, M., Graham, C. and Murray, M. 2009. Young women's use of a vaginal microbicide surrogate: The role of individual and contextual factors in acceptability and sexual pleasure. Journal of Sex Research, 46(1): 15-23.
33. UNAIDS. 2008. 2008 Report on the Global AIDS Epidemic, Geneva: UNAIDS.
34. UNFPA. 2010. AIDS clock. UNFPA.http://www.unfpa.org/aids_clock
35. World AIDS Campaign. 2009. Lead the change: Young women, HIV and sexual and reproductive health and rights. World AIDS Campaign.http://www.worldaidscampaign.org/en/Constituencies/Youth/Resources/Fact-Sheet-Young-Women-and-HIV